RecruitingRecruiting
Effects of Short and Long Courses of Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Including Elderly
NCT07574333 · National Medical Research Center for Therapy and Preventive Medicine
In plain English
Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.
Official title
A Single-Center Randomized Clinical Trial With Prospective Follow-up of the Efficacy and Safety of Short and Long Duration Intermittent Hypoxic-Hyperoxic Training in Patients With Type 2 Diabetes Mellitus Including Elderly Patients
About this study
This is a single-center randomized controlled trial evaluating the efficacy and safety of short (3 days) versus long (10 days) courses of intermittent hypoxic-hyperoxic training (IHHT) in patients with type 2 diabetes mellitus aged 50-74 years. Participants will be randomized into three groups: 3-day IHHT course (n≥100), 10-day IHHT course (n≥100), or control group receiving gas mixture with constant O2 21% for 10 days (n≥50). The primary outcomes are fasting glucose levels and HbA1c. Secondary outcomes include cardiovascular parameters, quality of life, cognitive function, and biological age.
Eligibility criteria
Inclusion Criteria:
* Age 50-74 years inclusive
* Type 2 diabetes mellitus confirmed by medical documentation
* Stable therapy for diabetes and other chronic diseases for at least 4 weeks prior to enrollment
* Ability to comply with study protocol requirements
* Signed informed consent
Exclusion Criteria:
* Type 1 diabetes mellitus
* Acute diabetes complications within 6 months (diabetic ketoacidosis, hyperosmolar hyperglycemic state, lactic acidosis, hypoglycemic coma)
* Acute or active chronic infections
* Angina pectoris functional class III-IV
* Uncontrolled grade 3 arterial hypertension (SBP ≥180 and/or DBP ≥110 mmHg)
* Acute cerebrovascular accident, myocardial infarction, surgical interventions, clinically significant injuries within 6 months
* Internal carotid artery stenosis \>60% and/or symptomatic stenosis 50-99%
* Chronic obstructive pulmonary disease and bronchial asthma
* Exacerbation and decompensation of chronic diseases within 1 month ALT and/or AST levels \>2-3 times upper limit of normal
* Congenital heart and major vessel abnormalities
* Implanted cardiac pacemaker
* Cancer with remission \<5 years
* Mental illness, drug addiction, alcohol dependence
* Pregnancy
* Inability to participate throughout the study period
Study design
Enrollment target: 250 participants
Allocation: randomized
Masking: single
Age groups: adult, older_adult
Timeline
Starts: 2025-10-15
Estimated completion: 2027-12-15
Last updated: 2026-05-07
Interventions
Other: Intermittent Hypoxic-Hyperoxic Training (3 days)Other: Intermittent Hypoxic-Hyperoxic Training (10 days)Other: Normoxic gas breathing
Primary outcomes
- • Change in fasting glucose level (mmol/L) from baseline to 30±3 days after intervention completion (Baseline, day 30)
- • Change in HbA1c (%) from baseline to 30±3 days after intervention completion (Baseline, day 30)
Sponsor
National Medical Research Center for Therapy and Preventive Medicine · other_gov
Contacts & investigators
ContactMikhail G Chashchin, PhD · contact · dr.chaschin@gmail.com · +79774331118
InvestigatorMarina I Smirnova, PhD · study_chair, National Medical Research Center for Therapy and Preventive Medicine
InvestigatorSvetlana A Berns, MD, Prof. · study_chair, National Medical Research Center for Therapy and Preventive Medicine
InvestigatorOksana M Drapkina, MD, Prof. · principal_investigator, National Medical Research Center for Therapy and Preventive Medicine
All locations (1)
National Medical Research Center for Therapy and Preventive MedicineRecruiting
Moscow, Russia